Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-11334

Stähli, B E; Camici, G G; Tanner, F C (2009). Drug-eluting stent thrombosis. Therapeutic Advances in Cardiovascular Disease, 3(1):45-52.

Accepted Version
View at publisher


Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS). Patient-, lesion-, and procedure-related factors as well as thrombogenicity of the stent itself are involved in the pathogenesis of stent thrombosis. Furthermore, early cessation of dual antiplatelet therapy correlates with an increased risk of stent thrombosis. This review focuses on clinical evidence and pathophysiological mechanisms of stent thrombosis with DES, particularly highlighting prothrombotic effects of the stent itself.




44 downloads since deposited on 13 Mar 2009
21 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Date:February 2009
Deposited On:13 Mar 2009 08:25
Last Modified:05 Apr 2016 12:53
Publisher:Sage Publications
Additional Information:Cardiovascular Research, Institute of Physiology, University of Zurich
Publisher DOI:10.1177/1753944708096280
PubMed ID:19124388

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page